The clinical development of products treating diseases of the central nervous system (CNS) is uniquely complex. Challenges include successful and timely patient enrolment and research and development. Onorach are involved in CNS trial strategy, development, and applications. Our team has substantial CNS/neurology experience.
There is a distinct need for specialists in the development and execution of any biomarker-related strategy. In order to integrate biomarkers into clinical development plans, extensive specialist expertise in neurological disorders must be combined with drug development expertise and, in many cases, technology expertise (in fMRI, PET, etc). Onorach has over 20 years experience in this area.
Onorach has experience of integrating biomarker strategies into clinical development plans at both strategic and operational level for neurological and psychiatric indications and for a wide range of biological drug targets in central and peripheral nervous systems.
Onorach can achieve faster, more reliable results by utilising its expertise, services and experience in:
Subscribe to RSS Feed